Scholarlink

Background <p>Recombinant human growth hormone (GH) has long been used to promote growth in both children and adults. While its benefits on height and weight gain are well-documented, concerns remain regarding potential adverse effects.</p> Main body <p>This scoping review analyzes placebo-controlled prospective clinical trials, randomized controlled trials, and retrospective studies conducted between January 2013 and December 2024. Here, over summarized 90 studies examine the effects of GH on indices of growth and strength in both pediatric and adult populations. Although GH therapy has shown efficacy in promoting physical growth, it has also been associated with significant adverse events, including cardiac dysfunction and cerebrovascular disease.</p> Conclusion <p>By summarizing the adverse outcomes reported in recent studies, this review aims to inform clinical decision-making and improve the safety of GH therapy in future patient care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Adverse events with usage of human growth hormone: a review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月6日

查看全文
  • Ludwik K. Branski,
  • Sarita Thanedar,
  • Nafis Deen,
  • Kevin W. Cho,
  • Gongkai Liu,
  • Gabriel Hundeshagen,
  • David N. Herndon,
  • Linda E. Sousse

摘要

Background

Recombinant human growth hormone (GH) has long been used to promote growth in both children and adults. While its benefits on height and weight gain are well-documented, concerns remain regarding potential adverse effects.

Main body

This scoping review analyzes placebo-controlled prospective clinical trials, randomized controlled trials, and retrospective studies conducted between January 2013 and December 2024. Here, over summarized 90 studies examine the effects of GH on indices of growth and strength in both pediatric and adult populations. Although GH therapy has shown efficacy in promoting physical growth, it has also been associated with significant adverse events, including cardiac dysfunction and cerebrovascular disease.

Conclusion

By summarizing the adverse outcomes reported in recent studies, this review aims to inform clinical decision-making and improve the safety of GH therapy in future patient care.